Select country set
Menu Shopping cart 0,00 Search
Manufactured by BioVendor

Thrombomodulin (CD141) Human ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA, HRP-labelled antibody
  • Other names:CD141, Cluster of Differentiation 141, BDCA-3
  • Species:Human
Please select your region to see available products and prices.
Cat. No. Size Price

RGP003R 96 wells (1 kit)
PubMed Product Details
Technical Data


Sandwich ELISA, HRP-labelled antibody


Serum, Plasma, Cell culture supernatant

Sample Requirements

100 µl/well


At ambient temperature. Upon receipt, store the product at the temperature recommended below.


Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Curve

Calibration Range

0.625–20 ng/ml

Limit of Detection

< 0.38 ng/ml


Research topic

Cell surface proteins (sCD)


Thrombomodulin (CD141) is a 557 amino acid a glycosylated transmembrane protein and is a thrombin receptor located on endothelial cell surface. This surface glycoprotein forms a complex with thrombin that activates protein C, which, in turn, degrades clotting factors V and VIII. Thus, thrombomodulin converts thrombin into a physiologic anticoagulant. Thrombomodulin is also found in the circulatory and urinary systems.

Product References (7)


  • de Leeuw K, Blaauw J, Smit A, Kallenberg C, Bijl M. Vascular responsiveness inthe microcirculation of patients with systemic lupus erythematosus is notimpaired. Lupus. 2008 Nov;17(11):1010-7. doi: 10.1177/0961203308091968. PubMedPMID: 18852225. See more on PubMed
  • de Leeuw K, Freire B, Smit AJ, Bootsma H, Kallenberg CG, Bijl M. Traditionaland non-traditional risk factors contribute to the development of acceleratedatherosclerosis in patients with systemic lupus erythematosus. Lupus.2006;15(10):675-82. PubMed PMID: 17120595. See more on PubMed
  • de Leeuw K, Sanders JS, Stegeman C, Smit A, Kallenberg CG, Bijl M. Acceleratedatherosclerosis in patients with Wegener's granulomatosis. Ann Rheum Dis. 2005May;64(5):753-9. Epub 2004 Sep 16. PubMed PMID: 15374854; PubMed Central PMCID:PMC1755479. See more on PubMed
  • Jie KE, van der Putten K, Bergevoet MW, Doevendans PA, Gaillard CA, Braam B,Verhaar MC. Short- and long-term effects of erythropoietin treatment onendothelial progenitor cell levels in patients with cardiorenal syndrome. Heart. 2011 Jan;97(1):60-5. doi: 10.1136/hrt.2010.194654. Epub 2010 Nov 11. PubMed PMID:21071558; PubMed Central PMCID: PMC3002834. See more on PubMed
  • Rega-Kaun G, Kaun C, Ebenbauer B, Jaegersberger G, Prager M, Wojta J,Hohensinner PJ. Bariatric surgery in morbidly obese individuals affects plasmalevels of protein C and thrombomodulin. J Thromb Thrombolysis. 2019Jan;47(1):51-56. doi: 10.1007/s11239-018-1744-9. PubMed PMID: 30259314; PubMedCentral PMCID: PMC6336753. See more on PubMed
  • Skrabal CA, Choi YH, Kaminski A, Steiner M, Kundt G, Steinhoff G, Liebold A.Circulating endothelial cells demonstrate an attenuation of endothelial damage byminimizing the extracorporeal circulation. J Thorac Cardiovasc Surg. 2006Aug;132(2):291-6. PubMed PMID: 16872952. See more on PubMed
  • Yano Y, Kitagawa N, Gabazza EC, Morioka K, Urakawa H, Tanaka T, Katsuki A,Araki-Sasaki R, Hori Y, Nakatani K, Taguchi O, Sumida Y, Adachi Y. Increasedplasma thrombin-activatable fibrinolysis inhibitor levels in normotensive type 2 diabetic patients with microalbuminuria. J Clin Endocrinol Metab. 2003Feb;88(2):736-41. PubMed PMID: 12574207. See more on PubMed
Related Products Docs